MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia

Kirsten Canté-Barrett(Erasmus MC - Sophia Children’s Hospital), Jules P.P. Meijerink(Erasmus MC - Sophia Children’s Hospital)

Leukemia

April 22, 2016

10.1038/leu.2016.83

Cited by 91

Related Papers

Thymocyte Negative Selection Is Mediated by Protein Kinase C- and Ca2+-Dependent Transcriptional Induction of Bim

|The Journal of Immunology|2006|66

Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategies

|Nature Communications|2022|31

Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia

|Cell Reports|2023|10